As of June 03, 2025, Paul Hartmann (PHH2.F) has a market cap of $1.02 billion USD. According to our data, Paul Hartmann is ranked No.5142 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jun 03, 2025 | $1.02 B |
18.30%
|
Dec 30, 2024 | $0.87 B |
11.07%
|
Dec 29, 2023 | $0.78 B |
2.62%
|
Dec 30, 2022 | $0.76 B |
-36.70%
|
Dec 30, 2021 | $1.20 B |
-3.38%
|
Dec 30, 2020 | $1.24 B |
28.99%
|
Dec 30, 2019 | $0.96 B |
-1.21%
|
Dec 28, 2018 | $0.98 B |
-28.26%
|
Dec 29, 2017 | $1.36 B |
7.84%
|
Dec 30, 2016 | $1.26 B |
-7.62%
|
Dec 30, 2015 | $1.36 B |
37.64%
|
Dec 30, 2014 | $0.99 B |
23.15%
|
Dec 30, 2013 | $0.80 B |
22.19%
|
Dec 28, 2012 | $0.66 B |
22.63%
|
Dec 30, 2011 | $0.54 B |
-19.20%
|
Dec 30, 2010 | $0.66 B |
46.85%
|
Dec 30, 2009 | $0.45 B |
5.71%
|
Dec 30, 2008 | $0.43 B |
-1.62%
|
Dec 28, 2007 | $0.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Johnson & Johnson
JNJ
|
$372.11 B |
-0.002 M
|
![]() USA
|
![]() Medtronic
MDT
|
$109.35 B |
0.003 M
|
![]() Ireland
|
![]() Becton Dickinson
BDX
|
$49.02 B |
0.002 M
|
![]() USA
|
![]() Cardinal Health
CAH
|
$37.15 B |
-0.001 M
|
![]() USA
|
![]() Baxter
BAX
|
$15.39 B |
-0.000 M
|
![]() USA
|
![]() 3M
MMM
|
$79.66 B |
0.003 M
|
![]() USA
|
![]() Stryker Corporation
SYK
|
$145.54 B |
-0.001 M
|
![]() USA
|
![]() Abbott Laboratories
ABT
|
$231.74 B |
-0.002 M
|
![]() USA
|
![]() Boston Scientific
BSX
|
$152.44 B |
-0.015 B
|
![]() USA
|
![]() Zimmer Biomet
ZBH
|
$18.15 B |
-0.001 M
|
![]() USA
|
![]() Hologic
HOLX
|
$14.05 B |
-0.000 M
|
![]() USA
|
![]() Danaher
DHR
|
$137.37 B |
0.003 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$151.31 B |
-0.024 B
|
![]() USA
|
![]() Philips
PHG
|
$21.32 B |
0.211 B
|
![]() Netherlands
|
![]() Fresenius Medical Care
FMS
|
$16.68 B |
0.000 M
|
![]() Germany
|
Market Cap | = | PHH2.F Stock Price | * | PHH2.F Shares Outstanding |
= | $288.56 | * | 3.55 M | |
= | $1.02 B |